MAPT and Alzheimer disease: Utility of p-Tau in early diagnosis: p-Tau biomarkers, particularly p-Tau181 and p-Tau217, are promising candidates for early AD diagnosis and monitoring, showing high specificity for tau-mediated neurodegeneration.